Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?

Calmy, Alexandra

doi:10.1111/hiv.12536

Scientific article

English

Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?

ContributorsCalmy, Alexandra

Published inHIV Medicine, vol. 19, no. 1, p. 42-48

Publication date2018

Abstract

The aim of the study was to evaluate differences in immunovirological response to combination antiretroviral therapy (cART) in migrant and native men and women within a European collaboration of HIV cohorts Collaboration of Observational HIV Epidemiological Research in Europ (COHERE) in EuroCoord, 2004-2013.

Keywords

Adolescent
Adult
Aged
Anti-Retroviral Agents/therapeutic use
Antiretroviral Therapy, Highly Active
CD4 Lymphocyte Count
Cohort Studies
Europe
Female
HIV Infections/drug therapy
Humans
Male
Middle Aged
Population Groups
RNA, Viral/blood
Transients and Migrants
Treatment Outcome
Viral Load
Young Adult

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

VIH/SIDA (930)

Citation (ISO format)

CALMY, Alexandra. Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all? In: HIV Medicine, 2018, vol. 19, n° 1, p. 42–48. doi: 10.1111/hiv.12536

Article (Published version)

Identifiers

PID : unige:115834
DOI : 10.1111/hiv.12536
PMID : 28741837

Journal ISSN1464-2662

333views

0downloads

Creation06/11/2018 17:38:00

First validation06/11/2018 17:38:00

Update time15/03/2023 17:06:57

Status update15/03/2023 17:06:57

Last indexation31/10/2024 14:09:54

Archive ouverte UNIGE

Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?

Technical informations